Ignite Creation Date:
2024-05-06 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03553823
Status:
COMPLETED
Last Update Posted:
2021-10-11
First Post:
2018-05-15
Brief Title:
Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-14
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-15
First Submit QC Date:
May 30 2018
Study First Post Date:
2018-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-02-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-07
Last Update Post Date:
2021-10-11
Last Update Post Date Type:
ACTUAL